Core Scientific, Inc. (NASDAQ:CORZ) has been upgraded by Citizens to “Market Outperform” with a price target of $30.00, citing strong HPC growth potential. The firm believes CORZ can secure more favorable contract terms with AI firms post-CoreWeave merger failure. Analysts view the company as undervalued and transitioning into an AI business.

Read more at Yahoo Finance: Citizens Upgrades Core Scientific (CORZ) as HPC Growth Outlook Strengthens